Aug 21, 2025 06:33PM
Aug 21, 2025 06:33PM
Aug 15, 2025 05:22PM
Jul 3, 2025 05:27PM
Apr 23, 2025 08:00AM
Apr 22, 2025 08:00AM
Jan 29, 2025 08:00AM Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5
Dec 12, 2024 06:13AM
Nov 13, 2024 04:33PM
Nov 13, 2024 04:33PM
Nov 12, 2024 05:29PM
Oct 23, 2024 08:33AM
Oct 23, 2024 08:31AM
Aug 13, 2024 05:37PM Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
Jul 5, 2024 04:20PM
Jul 5, 2024 04:15PM
Jun 27, 2024 07:03AM
Jun 27, 2024 07:00AM
Jun 11, 2024 04:05PM
Jun 10, 2024 07:00AM
Jun 3, 2024 07:02AM Calidi Biotherapeutics (CLDI) Presents CLD-101 Phase 1 Trial Update, Preclinical Data Highlighting RTNova and CLD-201
Jun 3, 2024 07:00AM
May 14, 2024 04:05PM
May 1, 2024 07:00AM
Apr 19, 2024 04:05PM
Apr 16, 2024 08:31AM
Apr 16, 2024 08:31AM
Apr 15, 2024 06:35AM Form S-1/A Calidi Biotherapeutics,
Apr 9, 2024 07:06AM
Apr 9, 2024 07:00AM
Apr 8, 2024 04:41PM
Apr 2, 2024 05:30PM
Apr 1, 2024 06:04AM
Mar 15, 2024 04:05PM
Mar 11, 2024 07:00AM Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer
Feb 12, 2024 07:00AM
Feb 7, 2024 12:36PM
Jan 29, 2024 09:34AM
Jan 16, 2024 06:41AM
Jan 8, 2024 07:00AM
Jan 8, 2024 06:32AM
Dec 13, 2023 07:00AM Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit
Dec 12, 2023 05:25PM
Dec 12, 2023 07:02AM
Dec 12, 2023 07:00AM
Nov 20, 2023 07:02AM
Nov 20, 2023 07:00AM
Nov 14, 2023 04:05PM
Nov 3, 2023 07:02AM Calidi Biotherapeutics (CLDI) (CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity
Nov 3, 2023 07:00AM

67,019 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All